Human medicines European public assessment report (EPAR): Sugammadex Adroiq, sugammadex, Date of authorisation: 26/05/2023, Revision: 6, Status: Authorised

Human medicines European public assessment report (EPAR): Ervebo, Ebola Zaire vaccine (rVSV∆G-ZEBOV-GP, live), Date of authorisation: 11/11/2019, Revision: 13, Status: Authorised

Human medicines European public assessment report (EPAR): Elrexfio, elranatamab, Date of authorisation: 07/12/2023, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR): Aripiprazole Zentiva, aripiprazole, Date of authorisation: 25/06/2015, Revision: 13, Status: Authorised

Human medicines European public assessment report (EPAR): Intuniv, guanfacine, Date of authorisation: 17/09/2015, Revision: 13, Status: Authorised

Human medicines European public assessment report (EPAR): Alimta, pemetrexed, Date of authorisation: 20/09/2004, Revision: 29, Status: Authorised

Human medicines European public assessment report (EPAR): Irbesartan Hydrochlorothiazide Zentiva (previously Irbesartan Hydrochlorothiazide Winthrop), irbesartan,hydrochlorothiazide, Date of authorisation: 18/01/2007, Revision: 37, Status: Authorised

Human medicines European public assessment report (EPAR): Xospata, gilteritinib, Date of authorisation: 24/10/2019, Revision: 8, Status: Authorised

Mysimba

Human medicines European public assessment report (EPAR): Terrosa, teriparatide, Date of authorisation: 04/01/2017, Revision: 7, Status: Authorised